The Stochastic Oscillator for AKAN moved out of overbought territory on January 07, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 12 similar instances where the indicator exited the overbought zone. In of the 12 cases the stock moved lower. This puts the odds of a downward move at .
The Momentum Indicator moved below the 0 level on January 08, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on AKAN as a result. In of 49 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AKAN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence (MACD) for AKAN just turned positive on December 23, 2024. Looking at past instances where AKAN's MACD turned positive, the stock continued to rise in of 26 cases over the following month. The odds of a continued upward trend are .
AKAN moved above its 50-day moving average on December 31, 2024 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for AKAN crossed bullishly above the 50-day moving average on January 06, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 5 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where AKAN advanced for three days, in of 118 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.058) is normal, around the industry mean (58.527). P/E Ratio (0.000) is within average values for comparable stocks, (90.460). AKAN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.947). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (0.174) is also within normal values, averaging (19.547).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. AKAN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AKAN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.
Industry PharmaceuticalsOther
A.I.dvisor tells us that AKAN and ACB have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AKAN and ACB's prices will move in lockstep.
Ticker / NAME | Correlation To AKAN | 1D Price Change % | ||
---|---|---|---|---|
AKAN | 100% | -5.39% | ||
ACB - AKAN | 27% Poorly correlated | -2.78% | ||
OGI - AKAN | 25% Poorly correlated | -1.27% | ||
SNOA - AKAN | 25% Poorly correlated | -0.38% | ||
SNDL - AKAN | 24% Poorly correlated | -1.11% | ||
TLRY - AKAN | 23% Poorly correlated | +1.69% | ||
More |